The EU funded PATHSEEK consortium, made up of four partners, is working towards a concept of sequencing whole pathogen genomes, e.g. HIV…

It’s exciting to see that NGS-related bioinformatics advances are having an impact in clinical labs. We’ve been following that trend…

2015 IPA Winter Release We’re pleased to deliver several new features to Ingenuity® Pathway Analysis™, to increase your insight and…

Webinar Studies of differential gene expression patterns using micro-array and RNA-seq technologies provide insight into the molecular mechanisms responsible for…

It was a pleasure attending PAG 2016. We had a poster presentation and were hosting a workshop on advanced NGS data analysis…

We launched the Regulator Effects in Ingenuity Pathway Analysis (IPA) last year, and it’s been so gratifying to see how…

It was great attending AMP. We not only announced enhancements to our QIAGEN Clinical Insight (QCI™) solution, but we also met…

It’s a pleasure to announce the introduction of our new GeneReader NGS System. Now, we’re offering a complete product suite across all…

We are pleased to announce the introduction of the GeneReader NGS System. We are now offering a complete product suite across all…

HGMD® is widely accepted as the gold standard for information about published inherited disease mutations, but what makes it such…

Austin, here we come!  We’re getting AMPed up for the upcoming Association for Molecular Pathology 2015 annual meeting! Held at…

Your $1,000 genome will only cost $22 to analyze We’re committed to enabling our customers to analyze vast amounts of…